[HTML][HTML] High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
…, A Basle, A Bouhamama, C Galvez, AL Herr… - European Journal of …, 2020 - Elsevier
Background Cancer patients presenting with COVID-19 have a high risk of death. In this
work, predictive factors for survival in cancer patients with suspected SARS-COV-2 infection …
work, predictive factors for survival in cancer patients with suspected SARS-COV-2 infection …
Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of …
AL Herr, N Kabbara, CMS Bonfim… - Blood, The Journal …, 2010 - ashpublications.org
We analyzed risk factors influencing outcomes after related (R) human leukocyte antigen-identical
cord blood transplantation (CBT) for 147 patients with malignancies reported to …
cord blood transplantation (CBT) for 147 patients with malignancies reported to …
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group …
…, A Vora, MA Yesilipek, AL Herr… - Blood, The Journal …, 2013 - ashpublications.org
To describe the incidence, risk factors, and treatment of autoimmune diseases (ADs)
occurring after cord blood transplantation (CBT), we analyzed both CBT recipients reported to …
occurring after cord blood transplantation (CBT), we analyzed both CBT recipients reported to …
Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases
…, A Ruggeri, D Purtill, K Boudjedir, AL Herr… - Best Practice & …, 2010 - Elsevier
Unrelated umbilical cord blood (UCB) has been widely used to treat patients lacking a well-matched
HLA donor. Cell dose is a critical determinant of outcomes in cord blood …
HLA donor. Cell dose is a critical determinant of outcomes in cord blood …
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.
M Hudson, AL Herr, J Rauch, C Neville… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To explore the effect of multiple prothrombotic risk factors in individuals with
anticardiolipin antibodies (aCL), we evaluated immunologic, coagulation, and genetic …
anticardiolipin antibodies (aCL), we evaluated immunologic, coagulation, and genetic …
Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation
AD Petropoulou, R Porcher, AL Herr, A Devergie… - …, 2010 - journals.lww.com
… Petropoulou participated in the writing of the manuscript and the performance of the research;
Raphael Porcher participated in data analysis; Andrée-Laure Herr participated in research …
Raphael Porcher participated in data analysis; Andrée-Laure Herr participated in research …
[HTML][HTML] Management of patients with pancreatic ductal adenocarcinoma in the real-life setting: lessons from the french national hospital database
Simple Summary With an increasing incidence, late diagnosis, and high mortality rate,
pancreatic adenocarcinoma remains, in 2021, a real challenge for health institutions and …
pancreatic adenocarcinoma remains, in 2021, a real challenge for health institutions and …
Is severe intestinal chronic graft-versus-host disease an indication for surgery? A report of two cases
AL Herr, JF Latulippe, S Carignan, A Mitchell… - …, 2004 - journals.lww.com
Chronic graft-versus-host disease (cGVHD) frequently complicates allogeneic hematopoietic
stem cell transplantation (HSCT), but small bowel involvement with obstruction is rarely …
stem cell transplantation (HSCT), but small bowel involvement with obstruction is rarely …
[HTML][HTML] Influence of myeloablative conditioning regimens on outcomes after single unrelated cord blood transplantation for adults with leukemia: an analysis on behalf …
…, I Ionescu, R Bizzetto, K Boudjedir, W Chaves, AL Herr… - Blood, 2008 - Elsevier
Cyclophosphamide (CY) associated to high dose total body irradiation (TBI) or busulfan (BU)
is the gold standard of myeloablative conditioning regimen (MAC) in allogeneic …
is the gold standard of myeloablative conditioning regimen (MAC) in allogeneic …
Vers une métropolisation des soins de cancer? Analyse géographique de l'évolution des parcours de soins depuis le début des années 2000
Y Fayet, A Drouet, V Lucas-Gabrielli, AL Herr… - CIST2020-Population …, 2020 - hal.science
Les progrès enregistrés en cancérologie depuis plusieurs décennies ont permis une
amélioration significative de la survie des patients mais ont aussi favorisé une centralisation des …
amélioration significative de la survie des patients mais ont aussi favorisé une centralisation des …